Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

10.37
-0.0600-0.58%
Volume:10.92K
Turnover:113.60K
Market Cap:337.65M
PE:-11.13
High:10.53
Open:10.42
Low:10.29
Close:10.43
Loading ...

NeuroPace Is Maintained at Overweight by Wells Fargo

Dow Jones
·
14 Nov 2024

Neuropace Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

NeuroPace price target lowered to $13 from $15 at Wells Fargo

TIPRANKS
·
13 Nov 2024

Neuropace Inc : Wells Fargo Cuts Target Price to $13 From $15

THOMSON REUTERS
·
13 Nov 2024

NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...

GuruFocus.com
·
13 Nov 2024

NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
13 Nov 2024

NeuroPace reports Q3 EPS (19c), consensus (27c)

TIPRANKS
·
13 Nov 2024

NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M

TIPRANKS
·
13 Nov 2024

NeuroPace Inc.: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

NeuroPace Q3 2024 GAAP EPS $(0.19) Beats $(0.29) Estimate, Sales $21.060M Beat $19.079M Estimate

Benzinga
·
13 Nov 2024

Neuropace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

THOMSON REUTERS
·
13 Nov 2024

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

GlobeNewswire
·
13 Nov 2024

private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week

Simply Wall St.
·
09 Nov 2024

Neuropace Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Neuropace Announces FDA Submission of Three-Year Data From Post-Approval Study of the Rns System in Focal Epilepsy

THOMSON REUTERS
·
05 Nov 2024

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

GlobeNewswire
·
05 Nov 2024

Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?

Zacks
·
28 Oct 2024

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

GlobeNewswire
·
23 Oct 2024